Colorectal Cancer News From Medical News Today Latest Health News and Medical News posted throughout the day, every day.
Irritable Bowel Syndrome Patients Not More Likely To Get Colon Cancer
Patients with irritable bowel syndrome are at no greater risk of having polyps, colon cancer or inflammatory bowel diseases than healthy people undergoing colonoscopies, according to new research published in the American Journal of Gastroenterology. "Patients and doctors get nervous about the symptoms of irritable bowel syndrome (IBS)," says William D. Chey, M.D...
News From The Annals Of Family Medicine: March/April 2010
Convenience of Retail Health Clinics Attractive to Patients The time and cost savings offered by retail clinics are attractive to patients, and they are likely to seek care for minor illnesses there given sufficient cost savings, according to a telephone survey of nearly 500 adults...
Colorectal Cancer In China
The incidence of colorectal cancer (CRC) in China is lower than that in the west countries, but has increased in recent years and become a substantial cancer burden in China, particularly in the more developed areas. Some studies have reported changes in the characteristics of CRC in China...
Obesity Associated With Risk Of Colorectal Tumors Without Microsatellite Instability
The increased risk of colorectal cancer associated with obesity may be largely restricted to tumors that have no or low microsatellite instability (MSI), a common condition in most colorectal cancers, according to a new study published online March 8 in the Journal of the National Cancer Institute...
Physicians Come Together On National Colorectal Cancer Awareness And Screening Day
Colorectal cancer (CRC) is the third leading cause of cancer death among men and women nationwide, yet only half of people who need CRC screening receive it. The American Gastroenterological Association (AGA) Institute is working to educate patients about the importance of screening and to encourage everyone age 50 and older to get screened for CRC...
A New Indicator Of Poor Prognosis In Node-Negative Colorectal Cancer Patients
Tumor budding at the invasive tumor front of colorectal cancer is recognized as an independent prognostic factor significantly related to both lymph node and distant metastasis...
The Right Colorectal Cancer Test For The Right Patient
Recent reports of President Obama's CT colonography, or virtual colonoscopy, as a screening test for colorectal cancer and coverage by the Associated Press of an NIH State-of-the-Science conference heralding stool blood tests as an inexpensive alternative to colonoscopy may leave many consumers wondering which colorectal cancer test is best for them...
The Right Colorectal Cancer Test For The Right Patient
Recent reports of President Obama's CT colonography, or virtual colonoscopy, as a screening test for colorectal cancer and coverage by the Associated Press of an NIH State-of-the-Science conference heralding stool blood tests as an inexpensive alternative to colonoscopy may leave many consumers wondering which colorectal cancer test is best for them...
Sociodemographic Characteristics Are Related To A Patient's Willingness To Participate In Cancer Screenings
Boston University School of Medicine's (BUSM) researchers have found that sociodemographic characteristics are related to a patients' willingness to participate in cancer screenings. They found this was more important than both attitudinal barriers and medical facilitors. This study appears in the March issue of the Journal of the National Medical Association...
Celsion Plans To Launch Phase II Program To Study ThermoDox(R) In Combination With RFA For Colorectal Liver Metastases
Celsion Corporation (Nasdaq: CLSN) announced that it will initiate a Randomized Phase II Study of Lyso-Thermosensitive Liposomal Doxorubicin (ThermoDox®) and Radiofrequency Ablation (RFA) for Colorectal Liver Metastases (CRLM). Dr. Steven K...
Gene Signature May Improve Colon Cancer Treatment
A gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence, according to a recent study by Vanderbilt-Ingram Cancer Center researchers...
Light Sciences Oncology Meets A Major Milestone In Aptocine Development With Target Enrollment In Phase 3 MCRC Trial
Light Sciences Oncology, Inc. (LSO) announced the achievement of a major milestone in its late-stage clinical development of Aptocineâ„¢ (talaporfin sodium) for treatment of solid tumors. LSO's global Phase 3 trial of Aptocine in metastatic colorectal cancer (MCRC) has reached target enrollment of 450 patients at 52 sites...
Digestive CAREâ„¢ Launches Bottom Line Song Title Contest For National Colorectal Cancer Awareness Month
Digestive CAREâ„¢, a medical group of more than 50 gastroenterologists in Broward and Palm Beach County, launched the "Bottom Line Song Title Contest" to bring awareness to National Colorectal Cancer Awareness Month (March 2010). Digestive CAREâ„¢ is urging people to go to the Web site http://www.DigestiveCareOnline...
Those Who Have Colonoscopy Performed By GIs Less Likely To Develop Colorectal Cancer
Following a negative complete colonoscopy, those who had their colonoscopies at a hospital and had their procedures performed by a non-gastroenterologist may be at a significantly increased risk of developing subsequent colorectal cancer (CRC), according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute...
Phase III Study Of Avastin Plus Chemotherapy In Advanced Stomach Cancer Did Not Meet Primary Endpoint
Genentech, Inc., a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that a Phase III study (AVAGAST) did not meet its primary endpoint of showing Avastin® (bevacizumab) plus Xeloda® (capecitabine) or 5-FU and cisplatin chemotherapy extended the lives of people with inoperable or advanced stomach (gastric) cancer, compared to chemotherapy alone...
Malaria Drug Tested For Colorectal Cancer Use
While new cases of colorectal cancer continue to decline in the United States, it remains the third leading cause of cancer death in the nation, according to the American Cancer Society...
Curis Announces Chugai's Exercise Of Japanese Development Rights For GDC-0449
Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, announced that Chugai Pharmaceutical Co., Ltd. (TSE: 4519) has exercised its right of first refusal for the development and commercialization in Japan of GDC-0449, a Hedgehog pathway inhibitor, under an existing agreement with F...
Gardasil Effective In Women Ages 25 To 45, Young Men, Merck Studies Show
Merck's human papillomavirus vaccine, Gardasil, effectively prevented precancerous cervical lesions and genital warts in women ages 24 through 45, and it prevented anal cancer and precancerous anal lesions in young men who have sex with men, according to two studies released by the company on Wednesday, the AP/Philadelphia Inquirer reports...
New Guideline Identifies Major Risk Factors In The Development Of Colorectal Cancer In Children And Adults With Inflammatory Bowel Disease
Certain patients with inflammatory bowel disease (IBD), both ulcerative colitis and Crohn's disease of the colon, have an increased risk of developing colorectal cancer compared to individuals without IBD...
Protein That Triggers Cancer Spread Discovered
Researchers in the US have discovered that a protein known as disabled 2 (Dab2) triggers cancer spread by switching on the process that allows cancer cells to migrate from the original tumor site and establish new tumors in other parts of the body...
Discovery Of Switch That Turns On The Spread Of Cancer
Reporting in Nature Cell Biology, researchers describe the discovery of a specific protein called disabled-2 (Dab2) that switches on the process that releases cancer cells from the original tumor and allows the cells to spread and develop into new tumors in other parts of the body...
Genetic 'Hotspots' Flag Up Opportunities For More Personal Bowel Cancer Treatment
Cancer Research UK scientists have identified the frequency of new genetic 'hotspots' which could help doctors to tailor therapies to as many as 3,000 additional bowel cancer patients each year, according to research published in the British Journal of Cancer today...
Health Discovery Corporation Inks Deal For Final Validation Of A New Molecular Diagnostic Test For Colon Cancer
Health Discovery Corporation (OTCBB: HDVY) announced today that the Company has entered into an exclusive agreement with the Pancreas, Biliary and Liver Surgery Center of New York at Saint Vincent Catholic Medical Centers in New York City to provide clinical specimens to be utilized to complete the final validation of HDC's molecular diagnostic test for colon cancer...
Racial Disparities Persist In The Diagnosis Of Advanced Breast Cancer And Colon Cancer In The U.S.
The incidence of advanced breast cancer diagnosis among black women remained 30 percent to 90 percent higher compared to white women between 1992 and 2004, according to new findings by researchers at Fred Hutchinson Cancer Research Center...
Phase I Trial Commences Treating Patients With Pancreatic And Colorectal Cancer Using Novel Monoclonal Antibody
Neogenix Oncology, Inc. (Neogenix) announced today that the Johns Hopkins Hospital has initiated a Phase I trial with the company's first therapeutic antibody, NPC-1C, in patients with late stage pancreatic or colorectal cancer...
Worlds Best Pharmacy
canadian meds shop
Why is your product so cheap? How do you ship orders? We accept : Visa, MasterCard, AmEx, Diners and JCB cards. |
